Squarepoint’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $682K | Sell |
44,105
-19,528
| -31% | -$302K | ﹤0.01% | 1732 |
|
|
2025
Q1 | $946K | Buy |
+63,633
| New | +$946K | ﹤0.01% | 1552 |
|
|
2024
Q4 | – | Sell |
-64,674
| Closed | -$920K | – | 3207 |
|
|
2024
Q3 | $920K | Buy |
+64,674
| New | +$920K | ﹤0.01% | 1479 |
|
|
2024
Q2 | – | Sell |
-66,760
| Closed | -$927K | – | 2964 |
|
|
2024
Q1 | $927K | Buy |
66,760
+41,656
| +166% | +$579K | ﹤0.01% | 1393 |
|
|
2023
Q4 | $358K | Buy |
+25,104
| New | +$358K | ﹤0.01% | 1874 |
|
|
2023
Q2 | – | Sell |
-48,110
| Closed | -$793K | – | 2825 |
|
|
2023
Q1 | $793K | Buy |
+48,110
| New | +$793K | ﹤0.01% | 1268 |
|
|
2022
Q1 | – | Sell |
-24,763
| Closed | -$338K | – | 2798 |
|
|
2021
Q4 | $338K | Buy |
+24,763
| New | +$338K | ﹤0.01% | 1804 |
|
|
2021
Q3 | – | Sell |
-13,276
| Closed | -$223K | – | 2728 |
|
|
2021
Q2 | $223K | Sell |
13,276
-4,753
| -26% | -$79.8K | ﹤0.01% | 2151 |
|
|
2021
Q1 | $329K | Buy |
+18,029
| New | +$329K | ﹤0.01% | 1821 |
|
|
2020
Q4 | – | Sell |
-37,434
| Closed | -$668K | – | 2868 |
|
|
2020
Q3 | $668K | Buy |
+37,434
| New | +$668K | 0.01% | 1148 |
|
|
2020
Q1 | – | Sell |
-13,148
| Closed | -$259K | – | 2427 |
|
|
2019
Q4 | $259K | Buy |
+13,148
| New | +$259K | ﹤0.01% | 2037 |
|
|
2019
Q2 | – | Sell |
-11,281
| Closed | -$230K | – | 2575 |
|
|
2019
Q1 | $230K | Buy |
+11,281
| New | +$230K | ﹤0.01% | 1837 |
|